Brent Sabatini - 01 Oct 2024 Form 3 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: SVP, Chief Accounting Officer
Signature: /s/ Vanina de Verneuil, Attorney-In-Fact
Issuer symbol: VIR
Transactions as of: 01 Oct 2024
Net transactions value: $0
Form type: 3
Filing time: 02 Oct 2024, 12:09:07 UTC
Next filing: 14 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VIR	Common Stock						28,439	01 Oct 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VIR	Stock Option (Right to Buy)							01 Oct 2024	Common Stock	30,000	$22.49	Direct	F1
holding	VIR	Stock Option (Right to Buy)							01 Oct 2024	Common Stock	30,000	$10.11	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4 of the shares subject to the stock option vested and became exercisable on February 13, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.
F2	1/4 of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.